Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ahren Innovation Capital is a venture capital firm founded in 2017, with headquarters in Cambridge and London, UK. The firm focuses on deep technology and deep science, aiming to generate significant returns by investing in transformational companies that address large-scale market needs. The founding team comprises experts whose combined technologies are valued at over $100 billion, providing a strong foundation for investment decisions.
As of 2023, Ahren manages over $800 million in assets across multiple funds, with their latest fund totaling $400 million. The firm operates globally, with a particular emphasis on the UK market. Ahren has established a reputation for backing companies at various stages, from pre-seed to pre-IPO, and emphasizes building strong relationships with exceptional founders and teams.
Ahren Innovation Capital invests in four primary domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. The firm targets companies at various stages, including pre-seed, seed, seed-plus, Series A, and pre-IPO, with typical check sizes ranging from $1 million to $5 million, depending on the stage of investment.
The firm seeks to partner with exceptional founders and teams, providing not only capital but also access to a network of world-class scientists and industry experts, including Nobel laureates. This unique model of 'patient and active capital' enhances the growth potential of their investments, allowing them to support companies that penetrate or create massive markets.
Ahren Innovation Capital's portfolio includes a diverse range of companies across various sectors:
Notably, the firm has achieved significant exits, including the acquisition of Adrestia by Insmed, which focuses on intractable genetic diseases. This diverse portfolio reflects Ahren's commitment to investing in groundbreaking science and high-end technology.
Alice Newcombe-Ellis: Founding & General Partner, with extensive experience in deep technology investments.
Peter Lourensz, FCA: Chief Financial Officer, responsible for financial strategy and operations.
Peter Baines: Venture Partner, bringing a wealth of industry knowledge and investment experience.
Joanna Green, PhD: Partner, specializing in deep science and technology investments.
Janusz Marecki, PhD: AI Partner, focusing on artificial intelligence and machine learning technologies.
Kaja Wasik, PhD: Entrepreneur in Residence, providing insights and guidance to portfolio companies.
Oliver Hedaux: Principal, involved in sourcing and evaluating investment opportunities.
Anuj Nanwani: Principal, contributing to the firm's investment strategy and portfolio management.
To pitch Ahren Innovation Capital, founders should visit their website and utilize the contact email provided. A comprehensive pitch deck is essential, including details about the technology, market opportunity, team, and financial projections. The firm prefers clear communication and well-prepared presentations.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial, as they can facilitate a more favorable review of the pitch.
In 2023, Ahren Innovation Capital announced the closing of their latest fund, totaling over $400 million, aimed at supporting deep technology and science ventures. The firm has been actively investing in notable companies, including Constructive Bio, which secured $58 million in Series A financing.
Ahren's portfolio continues to grow, with significant investments in companies like Mentee Robotics, which developed MenteeBot, a humanoid robot integrating AI across operational layers. The firm also celebrated the acquisition of Adrestia by Insmed, highlighting their successful exit in the biotech sector.
What are Ahren Innovation Capital's investment criteria?
Ahren focuses on deep technology and deep science, investing in companies across four primary domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. They target startups at various stages, from pre-seed to pre-IPO, and look for exceptional founders and teams.
How can I pitch to Ahren Innovation Capital?
Founders can pitch to Ahren by visiting their website and using the contact email provided. A well-prepared pitch deck should include details about the technology, market opportunity, team, and financial projections. The firm values strong relationships and clear communication.
What makes Ahren Innovation Capital different from other VCs?
Ahren differentiates itself by providing both capital and access to a network of world-class scientists and industry experts, including Nobel laureates. This model of 'patient and active capital' enhances the growth potential of their portfolio companies.
What is the typical check size for investments?
Ahren typically invests between $1 million and $5 million, depending on the stage of the company. This flexibility allows them to support startups at various points in their growth journey.
What is the geographic focus of Ahren Innovation Capital?
While Ahren operates globally, there is a strong emphasis on the UK market. They seek to partner with innovative companies worldwide that align with their investment thesis.
What kind of post-investment support does Ahren provide?
Ahren offers extensive support post-investment, including access to their network of scientists and industry experts. This involvement can include mentorship, operational support, and assistance with strategic decisions to help companies scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.